Cerliponase Alfa Observational Study in the US
Clinical trial NCT04476862 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04476862
- Sponsor
- BioMarin Pharmaceutical
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-08-19
- Primary completion
- 2030-08-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.